Use of a Novel Alpha-7 Nachr Antagonist to Suppress Pathogenic Signal Transduction in Cancer and Aids

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130231366A1
SERIAL NO

13772147

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This application provides a method for the use of select quaternary ammonium antagonists to alpha-7 nAChR for the treatment of cancer and HIV and AIDS.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION144 ASTECC BUILDING LEXINGTON KY 40506-0286

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CROOKS, Peter A Little Rock, US 79 1074
DWOSKIN, Linda P Lexington, US 30 118
HERNANDEZ, Gretchen Lopez Gainesville, US 2 6
PAPKE, Roger L Gainesville, US 9 25
THINSCHMIDT, Jeffrey S Gainesville, US 2 6
ZHANG, Zhenfa Lexington, US 6 9
ZHENG, Guangrong Lexington, US 32 68

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation